HANKANG CAPITAL
HANKANG CAPITAL
Status:
Active
Similar Organizations
Kunlun Capital
Kunlun Capital is an investment firm.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-18 | China Immunotech | Hankang Capital investment in Series B - China Immunotech | N/A |
| 2022-01-28 | HanBio Therapeutics | Hankang Capital investment in Series A - HanBio Therapeutics | 40 M USD |
| 2021-12-07 | Sumgen Biotech | Hankang Capital investment in Venture Round - Sumgen Biotech | N/A |
| 2021-01-07 | Abbisko Therapeutics | Hankang Capital investment in Series D - Abbisko Therapeutics | 123 M USD |
More informations about "Hankang Capital"
Hankang Capital investment portfolio - PitchBook
Founded in 2010, Hankang Capital (formerly Shanghai Jianxin Capital) is a venture capital firm of Zhongjianxin Group headquartered in Shanghai, China. It focuses on making investments in sectors like biomedicine, medical …See details»
Hankang Capital - Investor Profile, Portfolio & Team - Tracxn
Oct 28, 2024 Hankang Capital - Private equity fund investing in multiple sectors. Portfolio of 5 companies. Team has 3 members.See details»
Hankang Capital - Investments, Portfolio & Company Exits
Nov 1, 2024 Hankang Capital has had . obfuscated. obfuscated. exit, which was Abbisko Therapeutics. Which industries has this organization had the most exits in? Show . Abbisko …See details»
Hankang Capital - LinkedIn
Hankang Capital focuses on the in-depth research in major diseases and unmet clinical needs, promoting the establishment of startups with first-tier teams and technology platforms.See details»
Hankang Capital - Investments, Portfolio & Exits - Tracxn
Hankang Capital has a portfolio of 2 companies. Hankang Capital - Investments, Portfolio & Exits - Tracxn JavaScript is disabled in your browser. enable it to enjoy the full features of Tracxn.See details»
Hankang Capital - CB Insights
Jul 15, 2024 The round was led by existing investor, InnoPinnacle Fund, with participation from new investors including Yuanbio Venture Capital, Qiming Venture Partners, Hankang Capital, …See details»
汉康资本 | 投资机构信息-36氪
上海汉康私募基金管理有限公司（简称“汉康资本”）是一家专注于医药健康产业的风险投资基金。基金以“赋能医药创新，守护人类健康”为使命，携手一流科学家和企业家共同开发治疗重大疾病的突破性新药。汉康资本投资的企业：诺诚健 …See details»
Sirius Therapeutics Raised Nearly US$100 Million to ... - LinkedIn
Oct 19, 2023 This financing round was led by Hankang Capital, followed by Delos Capital, while OrbiMed and Creacion Ventures, two lead investors from the previous rounds of financing, …See details»
Hankang Capital — 11 Investments, Exits, 11 Portfolio companies ...
These funds often invest in the rounds preceeding the rounds of Hankang Capital: 1 CICC. 2 Jianxin Capital. 3 Temasek Holdings. Typical Co-investors. Hankang Capital is more likely to …See details»
HanKang Capital Fund Manager Profile - Preqin
Established in 2010, Hankang Capital is a private equity firm, the firm focuses on investments in the pharmaceutical, healthcare, consumer services, new ener...See details»
Jianxin Hankang RMB Fund: Performance | PitchBook
Jan 1, 2020 Jianxin Hankang RMB Fund is a 2017 vintage venture capital fund managed by Hankang Capital. The fund locates in Shanghai and will invest in China. The fund targets …See details»
Financing Progress | Maxvax Finishes C+ Funding
Hankang Capital is a venture capital fund focusing on the pharmaceutical and healthcare industries. With the mission of “empowering pharmaceutical innovation and safeguarding …See details»
Hankang Capital Fund Manager Profile | Preqin
Showing 2 of 2 known decision makers at Hankang Capital. Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers. Request a Demo to see …See details»
AlphaLife Sciences Completes A+ Financing for Clinical Research
Oct 12, 2022 Hankang Capital is a venture capital fund focused on the pharmaceutical and health industry. The fund's mission is "to empower pharmaceutical innovation and safeguard …See details»
Weifang Hankang RMB Fund: Performance - PitchBook
Weifang Hankang RMB Fund General Information Description. Weifang Hankang RMB Fund is a 2021 vintage venture capital fund managed by Hankang Capital. The fund is located in …See details»
Sirius Therapeutics Raised Nearly US$100 Million to Accelerate …
Oct 19, 2023 About Hankang Capital Hankang Capital is a healthcare-dedicated venture capital fund based in China and with a global vision. To fulfill Hankang’s mission in empowering …See details»
HanBio Therapeutics Announces the Completion of a US$40 …
Jan 28, 2022 Mr. Quanhong Yuan, Partner at Hankang Capital, said, "PD1/PDL1 antibodies have reshaped the landscape of cancer treatment, but they also face the problem of limited …See details»
DealShot: 11 Deals Exceeding $70 Million Counting Hankang …
Oct 13, 2022 China Money Network's DealShot provides detailed information on venture capital and private equity deals in China on a daily basis. Here you can find out ... China, chinese, …See details»
Paris dreams of becoming the capital of positive AI with the ...
22 hours ago France will host 100 heads of state and some 600 business and NGO leaders from the USA and Europe, as well as China and Africa.See details»